Close

Incyte (INCY) PT Raised to $121 at BMO Capital on Higher Probability of Epacadostat+Keytruda Sucecss

October 7, 2016 11:08 AM EDT Send to a Friend
BMO Capital analyst M. Ian Somaiya reiterated an Outperform rating and raised his price target on Incyte (NASDAQ: INCY) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login